Federal Register of Legislation - Australian Government

Primary content

PB 106 of 2010 Specifications as made
This instrument amends the National Health Act (Pharmaceutical Benefits - Early Supply) - specification under subsection 84AAA(2) Instrument 2009 (No. PB 30 of 2009) that lists the medicines for which Pharmaceutical Benefits Scheme Safety Net entitlements will not apply when the next supply of the same medicine is obtained within 20 days.
Administered by: Health
Registered 03 Nov 2010
Tabling HistoryDate
Tabled HR15-Nov-2010
Tabled Senate15-Nov-2010
Date of repeal 19 Mar 2014
Repealed by Health (Spent and Redundant Instruments) Repeal Regulation 2014

 

COMMONWEALTH OF AUSTRALIA

Instrument number PB 106 of 2010

National Health Act (Pharmaceutical Benefits – Early Supply) Amendment November 2010 - Specification Under Subsection 84AAA(2)

 

Amendment determination under subsection 84AAA(2) of the National Health Act 1953

 

I, Adriana Platona, Assistant Secretary, Pharmaceutical Evaluation Branch, Department of Health and Ageing, delegate of the Minister for Health and Ageing, make this Instrument under subsection 84AAA(2) of the National Health Act 1953.

 

Dated 29 October 2010

 

 

ADRIANA PLATONA

Assistant Secretary

Pharmaceutical Evaluation Branch

Department of Health and Ageing

 

 

 

Amendment determination — Pharmaceutical Benefits - Early Supply

 

 

1          Name of Instrument

 

(1)           This Instrument is the National Health Act (Pharmaceutical Benefits – Early Supply) Amendment November 2010 - specification under subsection 84AAA(2).

 

(2)           This Instrument may also be cited as “No. PB 106 of 2010”.


 

2          Commencement

 

This Determination commences on the later of the following:

(a) 1 November 2010;

(b) the day after it is registered.

 

3          Amendment of PB 30 of 2009

 

Schedule 1 amends the National Health (Pharmaceutical Benefits – Early Supply) Instrument 2009, PB 30 of 2009.

 


Schedule 1        Amendments

[1]                                  Schedule 1, after item dealing with Amlodipine with valsartan

insert in the columns in the order indicated:

 

Amlodipine with valsartan and hydrochlorothiazide

Tablet 5 mg (as besylate)-160 mg-12.5 mg

Oral

28

5

 

Tablet 5 mg (as besylate)-160 mg-25 mg

Oral

28

5

 

Tablet 10 mg (as besylate)-160 mg-12.5 mg

Oral

28

5

 

Tablet 10 mg (as besylate)-160 mg-25 mg

Oral

28

5

 

Tablet 10 mg (as besylate)-320 mg-25 mg

Oral

28

5

 

[2]                                  Schedule 1, after item dealing with Olmesartan

insert in the columns in the order indicated:

 

Olmesartan with amlodipine

Tablet containing olmesartan medoxomil 20 mg with amlodipine 5 mg (as besylate)

Oral

30

5

 

Tablet containing olmesartan medoxomil 40 mg with amlodipine 5 mg (as besylate)

Oral

30

5

 

Tablet containing olmesartan medoxomil 40 mg with amlodipine 10 mg (as besylate)

Oral

30

5